Gene · 780
Papers2,465
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,465
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DNA methylation and bronchiectasis: a Mendelian randomization analysis to investigate causal link and therapeutic target. | Epigenetics | 2025 | 40536885 | PubTator, text mining | PubMed |
| Author Correction: Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome. | Nature | 2025 | 40533566 | PubTator, text mining | PubMed |
| Interleukin-1β mediates a tumor-supporting environment prompted by IGF1 in triple-negative breast cancer (TNBC). | J Transl Med | 2025 | 40528195 | PubTator, text mining | PubMed |
| Cracking the Kinase Code: Urinary Biomarkers as Early Alarms for AAA Rupture-A Pilot Study. | J Clin Med | 2025 | 40507607 | PubTator, text mining | PubMed |
| Bridging chemical space and biological efficacy: advances and challenges in applying generative models in structural modification of natural products. | Nat Prod Bioprospect | 2025 | 40478370 | PubTator, text mining | PubMed |
| ANKRD17 induces pro-survival signaling pathways that enhance cellular invasion and migration during hepatocellular carcinoma tumorigenesis. | iScience | 2025 | 40458187 | PubTator, text mining | PubMed |
| Overexpression of DDR1 contributes to gastric cancer progression by inhibiting the Hippo pathway. | J Biomed Res | 2025 | 40456688 | PubTator, text mining | PubMed |
| Artificial Intelligence in Molecular Optimization: Current Paradigms and Future Frontiers. | Int J Mol Sci | 2025 | 40430017 | PubTator, text mining | PubMed |
| The Overexpression of Collagen Receptor DDR1 is Associated With Chromosome Instability and Aneuploidy in Diffuse Large B-Cell Lymphoma. | J Cell Mol Med | 2025 | 40401507 | PubTator, text mining | PubMed |
| Targeted degradation of DDR1 by proteolytic targeting chimera reverses immune exclusion for tumor immunotherapy. | Eur J Med Chem | 2025 | 40382838 | PubTator, text mining | PubMed |
| Canonical and non-canonical roles of oligodendrocyte precursor cells in mental disorders. | Npj Ment Health Res | 2025 | 40374740 | PubTator, text mining | PubMed |
| Mechanistic insights into Circ-MBOAT2-mediated regulation of TLK1 through miR-664b-3p in non-small cell lung cancer. | Hereditas | 2025 | 40369698 | PubTator, text mining | PubMed |
| Recent Advances in the Development and Application of Cell-Loaded Collagen Scaffolds. | Int J Mol Sci | 2025 | 40362249 | PubTator, text mining | PubMed |
| ICVAE: Interpretable Conditional Variational Autoencoder for De Novo Molecular Design. | Int J Mol Sci | 2025 | 40362221 | PubTator, text mining | PubMed |
| DCAF8L1 induces branching morphogenesis and hollow acinar structures remodeling of MCF10A cells in 3D culture by upregulating DDR1. | Biochem Biophys Res Commun | 2025 | 40239542 | PubTator, text mining | PubMed |
| Discovery of Novel DDR1 Inhibitors through a Hybrid Virtual Screening Pipeline, Biological Evaluation and Molecular Dynamics Simulations. | ACS Med Chem Lett | 2025 | 40236534 | PubTator, text mining | PubMed |
| Emerging strategies and translational advancements of DDR1 in oncology. | Discov Oncol | 2025 | 40159417 | PubTator, text mining | PubMed |
| DDR1 Targeting HOXA6 Facilitates Bladder Cancer Progression via Inhibiting Ferroptosis. | J Cell Mol Med | 2025 | 40105492 | PubTator, text mining | PubMed |
| Stiffness regulates extracellular matrix synthesis in fibroblasts by DDR1-TGF-β/STAT3 mechanotransduction axis. | Biomater Adv | 2025 | 40023083 | PubTator, text mining | PubMed |
| Comparative RNA-Seq analysis of differentially expressed genes in the sertoli cells of yak and cattle-yak. | BMC Vet Res | 2025 | 39987073 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/780/papers?page=7